"Vista Health Research, LLC is a multi-specialized research facility that conducts Phase I - IV clinical research studies. Our facility adheres to the highest standards In the industry. We our proud to provide our community with the opportunity to Better our Future due to the work we do here."

During the past decade, Vista Health Research conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 6 clinical trials were completed, i.e. on average, 24% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vista Health Research" #1 sponsor was "Celgene" with 4 trials, followed by "Galapagos NV" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Longeveron Inc." with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vista Health Research" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Novum Pharmaceutical Research Services" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Vista Health Research" are "Crohn Disease" (4 trials), "Crohn's Disease" (3 trials), "Aging Frailty" (2 trials), "Atopic Dermatitis" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Vista Health Research" in a lesser frequency.

Most popular intervention types in "Vista Health Research" are "Drug" (21 trials), "Other" (8 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Ozanimod" (4 trials), "Filgotinib" (2 trials), "Longeveron Mesenchymal Stem Cells (LMSCs)" (2 trials) and "011516X (New Artificial Tear Formulation)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vista Health Research" are 24 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Vista Health Research". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in Vista Health Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Vista Health Research, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".